Medical Equipment

Cardiac Marker Testing Market 2026–2030: Forecasting Business Opportunities Ahead

February 2, 2026February 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the software as a service (saas)-based human resource management (hrm) market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Cardiac Marker Testing Market between 2026 and 2030?_x000D_

The cardiac marker testing market size has seen rapid growth in recent years. It is forecast to increase from $7.19 billion in 2025 to $7.93 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.3%. Historically, this expansion was driven by factors such as the limited availability of high-sensitivity cardiac marker tests, a reliance on centralized laboratory testing, the growing prevalence of cardiovascular diseases, increasing awareness among healthcare providers, and conventional manual diagnostic practices._x000D_

_x000D_

The cardiac marker testing market is projected to experience substantial expansion over the coming years. This market is anticipated to reach a valuation of $11.61 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.0%. This anticipated growth during the forecast period can be primarily attributed to several factors, including the emergence of automated and portable cardiac marker testing devices, the increasing integration of point-of-care diagnostics, better connectivity with digital health platforms, an expanding elderly demographic coupled with higher cardiovascular risk, and improvements in the sensitivity of reagents and kits. Key trends projected for this period encompass the increased acceptance of high-sensitivity cardiac biomarker tests, the broadening availability of point-of-care testing facilities, the incorporation of automated analyzers and immunoassay systems, the expanding application of cardiac marker testing within preventive cardiology, and a surge in the demand for portable diagnostic instruments._x000D_

_x000D_

#Access Your Free Sample Report for In-Depth Market Insights:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=19358&type=smp_x000D_

_x000D_

Which Drivers Are Expected To Impact The Cardiac Marker Testing Market During The Forecast Period?_x000D_

The growing occurrence of cardiovascular diseases is projected to propel the expansion of the cardiac marker testing market in the future. Cardiovascular diseases (CVDs) refer to a range of ailments affecting the heart and blood vessels, such as coronary artery disease, heart failure, and stroke. The increase in cardiovascular disease cases is attributed to factors like an unhealthy diet, insufficient physical activity, tobacco use, problematic alcohol consumption, and air pollution. Cardiac marker testing is crucial for cardiovascular diseases to accurately diagnose, determine the severity, and monitor the advancement or therapeutic response of heart conditions through the detection of specific biomarkers released during myocardial injury. For instance, in January 2024, data from the American Heart Association, a US-based nonprofit organization, indicated that the age-adjusted death rate from cardiovascular disease climbed to 233.3 per 100,000, marking a 4.0% rise from 224.4 per 100,000 when compared to 2023. Therefore, the escalating incidence of cardiovascular diseases is a key driver for the cardiac marker testing market._x000D_

_x000D_

How Is The Cardiac Marker Testing Market Divided Into Segments?_x000D_

The cardiac marker testing market covered in this report is segmented – _x000D_

_x000D_

1) By Product: Reagents And Kits, Instruments_x000D_

2) By Biomarker Type: Troponin I And T, Creatine Kinase-MB (CK-MB), Natriuretic Peptide, Myoglobin, High-Sensitivity C-Reactive Protein, Other Biomarker Types_x000D_

3) By Application: Laboratory Testing Facilities, Point-Of-Care Testing Facilities, Academic Institutions_x000D_

_x000D_

Subsegments:_x000D_

1) By Reagents and Kits: Troponin Test Kits, B-type Natriuretic Peptide (BNP) Test Kits, Creatine Kinase-MB (CK-MB) Test Kits, Myoglobin Test Kits, Other Cardiac Biomarker Reagents _x000D_

2) By Instruments: Point-Of-Care Testing Devices, Automated Analyzers, Immunoassay Systems, Portable Diagnostic Devices _x000D_

_x000D_

How Are Emerging Trends Affecting The Progression Of The Cardiac Marker Testing Market?_x000D_

Leading companies within the cardiac marker testing market are concentrating on developing technologically advanced products, such as cardiac assays, to provide valuable and precise information regarding heart health and function. Cardiac assays are diagnostic tests specifically designed to measure biomarkers or other indicators found in blood or other samples to assess heart function, diagnose cardiovascular diseases, or evaluate the risk of heart-related conditions. As an illustration, in October 2023, Mindray, a China-based medical device company, introduced its troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The hs-cTnI assay distinguishes itself with outstanding sensitivity, precision, and reliability, surpassing minimal requirements by achieving a 93% detection rate between the limit of detection (LoD) and the 99th percentile upper reference limit (URL) and maintaining an imprecision coefficient of variation (CV) below 5% at the 99th URL, rendering it highly effective in identifying myocardial injury. Furthermore, Mindray’s NT-proBNP assay serves as a vital cardiac marker for heart failure, exhibiting high precision with a coefficient of variation (CV) of =5%. It also successfully reduces interference from 55 prevalent heart disease medications, which ensures accurate detection and management of heart failure._x000D_

_x000D_

Which Major Firms Are Strengthening Their Position In The Cardiac Marker Testing Market?_x000D_

Major companies operating in the cardiac marker testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Tosoh Corporation, Guangzhou Wondfo Biotech Co. Ltd., Randox Laboratories Ltd., Getein Biotech Inc., Fujirebio Inc., Mayo Clinic Laboratories, Alere Inc., Nano-Ditech Corporation, Ortho Clinical Diagnostics, QuidelOrtho Corporation, DiaSorin S.p.A., PerkinElmer Inc., Meso Scale Diagnostics LLC, Boditech Med Inc., Response Biomedical Corp. _x000D_

_x000D_

#Access The Complete Report For Deeper Market Insights:#_x000D_

https://www.thebusinessresearchcompany.com/report/cardiac-marker-testing-global-market-report_x000D_

_x000D_

Which Region Is Anticipated To See The Fastest Growth In The Cardiac Marker Testing Market?_x000D_

North America was the largest region in the cardiac marker testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac marker testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Request Your Customized Cardiac Marker Testing Market Research Report for Competitive Advantage:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=19358&type=smp_x000D_

_x000D_

#Browse Through More Reports Similar to the Global Cardiac Marker Testing Market 2026, By The Business Research Company#_x000D_

_x000D_

Ventricular Assist Device Global Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report_x000D_

_x000D_

Left Ventricular Assist Devices Global Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/left-ventricular-assist-devices-global-market-report_x000D_

_x000D_